Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.17 USD -0.85% Market Closed
Market Cap: 425.2m USD

Wall Street
Price Targets

LXRX Price Targets Summary
Lexicon Pharmaceuticals Inc

Wall Street analysts forecast LXRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LXRX is 2.94 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

Lowest
Price Target
1.01 USD
14% Downside
Average
Price Target
2.94 USD
151% Upside
Highest
Price Target
6.3 USD
438% Upside
Lexicon Pharmaceuticals Inc Competitors:
Price Targets
TWST
Twist Bioscience Corp
21% Upside
BIOCON
Biocon Ltd
11% Upside
006280
Green Cross Corp
15% Upside
COYA
Coya Therapeutics Inc
199% Upside
ALEC
Alector Inc
49% Upside
GNFT
Genfit SA
77% Upside
4BB
4Basebio PLC
167% Upside
397030
AprilBio Co Ltd
6% Downside

Revenue
Forecast

Revenue Estimate
Lexicon Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

25%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Lexicon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Lexicon Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LXRX's stock price target?
Price Target
2.94 USD

According to Wall Street analysts, the average 1-year price target for LXRX is 2.94 USD with a low forecast of 1.01 USD and a high forecast of 6.3 USD.

What is Lexicon Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for Lexicon Pharmaceuticals Inc's revenue is 25%. The projected CAGR for the next 4 years is 19%.

Back to Top